(Q45273790)

11 December 2017

title

Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect (English)

1 reference

11 December 2017

Yajun Chen

1

1 reference

11 December 2017

Jie Liu

2

1 reference

11 December 2017

Xiangliang Yang

3

1 reference

11 December 2017

Xiaoling Zhao

4

1 reference

11 December 2017

Huibi Xu

5

1 reference

11 December 2017

publication date

1 February 2005

1 reference

Journal of Pharmacy and Pharmacology

11 December 2017

published in

1 reference

11 December 2017

volume

57

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

259-264

1 reference

Rapid dissolution of high-potency danazol particles produced by evaporative precipitation into aqueous solution

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Studies on the non-covalent complexes between oleanolic acid and cyclodextrins using electrospray ionization tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against leishmania infected macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Pharmacology of oleanolic acid and ursolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Nanosizing: a formulation approach for poorly-water-soluble compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Atomic force microscopy imaging of novel type of polymeric colloidal nanostructures

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Nanosuspensions: a promising drug delivery strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Bioactivation of halogenated hydrocarbons by cytochrome P4502E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Ampicillin micronization by supercritical assisted atomization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Solution-based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray-freezing technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Hepatoprotective action of an oleanolic acid-enriched extract of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055407

21 January 2018

Identifiers

DOI

10.1211/0022357055407

1 reference

11 December 2017

1 reference